Tags: SOCMA Member News


Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands

Lonza today announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The expanded collaboration will further extend the manufacture of the drug substance for the COVID-19 Vaccine Moderna and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Geleen (NL) site.

June 2, 2021



Ott Scientific Announces Acquisition of American Bionostica

Ott Scientific is pleased to announce its acquisition of American Bionostica, Inc. (ABI), a lateral flow development and manufacturing company, further diversifying the company's product portfolio within the health-care diagnostics space.

May 10, 2021




Ascensus Specialties Acquires Strem Chemicals

Wind Point Partners (“Wind Point”) and Ascensus Specialties LLC (“Ascensus”) today announced that Ascensus has completed the acquisition of Strem Chemicals, Inc. (“Strem” or the “Company”). Strem is a global leader in high-purity, research-grade catalysts, ligands, organometallics, metal carbonyls and CVD/ALD precursors.

April 7, 2021


Handheld Device Quickly and Accurately Detects Pathogens and Contaminants for Health, Food and Industrial Applications

Salvus™, part of the CJB family of companies, today announced the upcoming commercialization of a novel interferometric platform that provides highly accurate detection of contaminants or pathogens in many industries. Applicable in human and animal health, agriculture, water quality management, food processing and the chemical and transportation industries, Salvus detection technology features handheld detection in minutes with extreme specificity and at parts per trillion accuracy in many applications.

March 16, 2021